Junwei Sun News Today

VintaBio manufactures AAV and lentiviral vectors for entities pursuing clinical development of cell and gene therapies. The contract development manufacturing organization’s launch comes as demand for viral vectors continues to outpace the supply of these crucial components of the therapies.

BioPharma

RALEIGH - Opus Genetics recently announced it would open its third preclinical trial, just a few months after the company formed with a $19 million seed